Mammographic density changes in perimenopausal and postmenopausal women: Is effect of hormone replacement therapy predictable?

Breast Cancer Research and Treatment

Volumn 59, Issue 2, 2000, Pages 125-132

  Sterns, Ernest E ^a,c   Zee, Benny ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b Institut national du cancer du Canada   (Canada)

^c KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

Density; Hormone replacement therapy; Mammography; Menopause; Risk

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DENSITY; DIAGNOSTIC ACCURACY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; MENOPAUSE; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGE FACTORS; AGED; BREAST; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; MAMMOGRAPHY; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS;

EID: 0034007963     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006326432340     Document Type: Article

References (64)

1. 1. Fisher ER, Palekar A, Kim WS, Redmond C: Histopathology of mammographic patterns. Am J Clin Pathol 69: 421-426, 1978
2. 2. Wellings SR, Wolfe JN: Correlative studies of the histologic and radiographic appearanee of the breast parenchyma. Radiology 129: 299-306, 1978
3. 3. Page DL, Winfield AC: The dense mammogram. AJR 147: 487-489, 1986
4. 4. Bright RA, Morrison AS, Brisson J, Burstein NA, Sadowsky NS, Kopans DB, Meyer JE: Relationship between mammographic and histologic features of breast tissue in women with benign biopsies. Cancer 61: 266-271, 1988
5. 5. Krook PM: Mammographic parenchymal patterns as risk indicators for incident cancer in a screening program: an extended analysis. AJR 131: 1031 -1035, 1978
6. 6. Andersson I, Janzon L, Pettersson H: Radiographic patterns of mammary parenchyma; variations with age at examination and age at first birth. Radiology 138: 59-62, 1981
7. 7. Grove JS, Goodman MJ, Gilbert FI, Mi MP: Factors associated with mammographic pattern. Br J Radiol 58: 21-25, 1985
8. 8. Whitehouse GH, Leinster SJ: The variation of breast parenchymal patterns with age. Br J Radiol 58: 315-318, 1985
9. 9. Whitehead J, Carlile T, Kopecky KJ, Thompson DJ, Gilbert FI, Present AJ, Threatt Krook P, Hadaway E: Mammographic parenchymal patterns. A study of the masking hypothesis of Egan and Mosteller. Cancer 56: 1280-1286, 1985
10. 10. Saftlas AF, Szklo M: Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev 9: 146-174, 1987
11. 11. Hart BL, Steinbock RT, Mettler FA, Pathak DR, Bartlow SA: Age and race related changes in mammographic parenchymal patterns. Cancer 63: 2537-2539, 1989
12. 12. Brisson J, Verreault R, Morrison AS, Tennina S, Meyer F: Diet, mammographic features of breast tissue and breast cancer risk. Am J Epidemiol 130: 14-24, 1989
13. 13. van Gils CH, Otten JDM, Verbeek AL, Hendriks JH: Short communication: breast parenchymal patterns and their changes with age. Br J Radiol 68: 1133-1135, 1995
14. 14. Stomper PC, D'Souza DJ, DiNitto PA, Arredondo MA: Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR 167: 1261-1265, 1996
15. 15. Wolfe JN: The prominent duct pattern as an indicator of cancer risk. Oncology 23: 149-158, 1969
16. 16. Wilkinson E, Clopton C, Gordonson J, Green R, Hill A, Pike C: Mammographic parenchymal patterns and the risk of breast cancer. J Natl Cancer Inst 59: 1397-1400, 1977
17. 17. Hainline S, Myers L, McLellland R, Newell J, Grufferman R, Shingleton W: Mammographic pattern and risk of breast cancer. AJR 130: 1157-1158, 1978
18. 18. Egan RL, McSweeney M: Mammographic parenchymal patterns and risk of breast cancer. Radiology 133: 65-70, 1979
19. 19. Threatt B: Association between mammographic parenchymal pattern classification and incidence of breast cancer. Cancer 45: 2250-2256, 1980
20. 20. Gravelle IH, Bulstrode JC, Bullbrook RD, Wang DY, Allen D, Hayward JL: A prospective study of mammographic parenchymal patterns and risk of breast cancer. Br J Radiol 59: 487-491, 1986
21. 21. Goodwin PJ, Boyd NF: Mammographic parenchymal pattern and breast cancer risk: a critical appraisal of the evidence. Am J Epidemiol 127: 1097-1108, 1988
22. 22. Bartow SA, Pathak DR, Merrier FA: Radiographic microcalification and parenchymal pattern as indicators of histologic "high risk" benign breast disease. Cancer 66: 1721-1725, 1990
23. 23. Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M, Wolfe JN: Mammographic densities and risk of breast cancer. Cancer 67: 2833-2838, 1991
24. 24. Oza AM, Boyd NF: Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 15: 196-208, 1993
25. 25. Kalo I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG: A nested case control study of mammographic patterns, breast volume, and breast cancer. Cancer Causes Control 6: 431-438, 1995
26. 26. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R: Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87: 1622-1629, 1995
27. 27. Byng JW, Yaffe MJ, Lockwood GA, Little LE, Tritchler DL, Boyd NE: Automated analysis of mammographic densities and breast carcinoma risk. Cancer 80: 66-74, 1997
28. 28. Fajardo LL, Hillman BJ, Frey C: Correlation between breast parenchymal patterns and mammographers certainty of diagnosis. Invest Radiol 23: 505-508, 1988
29. 29. Bird RE, Wallace TW, Yankaskas BC: Analysis of cancer missed at screening mammography. Radiology 184: 613-617, 1992
30. 30. Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF: Case-control study of factors associated with failure to detect cancer by mammography. J Natl Cancer Inst 84: 781-785, 1992
31. 31. Kerlikowske K, Grady D, Barclay J, Sickels E, Ernster V: Do age, breast density, and family history affect the sensitivity of first screening mammography? JAMA 276: 33-38, 1996
32. 32. Persson I, Yuen J, Bergkvist L, Schairer C: Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy - long-term follow-up of a Swedish cohort. Internat J Cancer 67: 327-332, 1996
33. 33. Berkowitz JE, Gatewood OMB, Goldblum LE, Gayler BW: Hormonal replacement therapy: mammographic manifestations. Radiol 174: 199-201, 1990
34. 34. Cohen MEL: Effect of hormone replacement on cancer detection by mammography. (Letter) Lancet 349: 1624, 1997
35. 35. Erel CT, Seyisoglu H, Senturk ML, Akman C, Ersavasti G, Benian A, Uras C, Altug A, Ertungealp E: Mammographic changes in women on hormonal replacement therapy. Maturitas 25: 51-57, 1996
36. 36. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L: Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 196: 433-137, 1995
37. 37. Marugg RC, van der Mooren MJ, Hendriks JH, Rolland R, Ruijs SH: Mammographic changes in postmenopausal women on hormonal replacement therapy. Euro Radiol 7: 749-755, 1997
38. 38. Rand T, Heytmanek G, Seifert M, Wunderbaldinger P, Kreuzer S, Schneider B, Wolf G: Mammography in women undergoing hormone replacement therapy. Possible effects revealed at routine examination. Acta Radiolog 38: 228-231, 1997
39. 39. McNicholas MM, Heneghan JP, Milner MH, Tunney T, Hourihane JB, MacErlaine DP: Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. AJR 163: 311-315, 1994
40. 40. Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE: Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 174: 487-490, 1990
41. 41. Leung W, Goldberg F, Zee B, Sterns E: Mammographic density in women on postmenopausal hormone replacement therapy (HRT). Surgery 122: 669-674, 1997
42. 42. Harvey JA, Pinkerton JV, Herman CR: Short-term cessation of hormone replacement therapy and improvement of mammographic specificity. J Natl Cancer Inst 89: 1623-1625, 1997
43. 43. Peck DP, Lowman RM: Estrogen and the postmenopausal breast: mammographic considerations. JAMA 240: 1733-1735, 1978
44. 44. Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC: Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 86: 431-436, 1994
45. 45. Bergkvist L, Adami HO, Persson I, Bergstrom R, Krusemo UB: Prognosis after breast cancer diagnoses in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol 130: 221-228, 1989
46. 46. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl J Med 332: 1589-1593, 1995
47. 47. Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047-1059, 1997
48. 48. Ewertz M: Hormone therapy in the menopause and breast cancer risk - a review. Maturitas 23: 241-246, 1996
49. 49. Hunt K, Vessey M, McPherson K: Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 97: 1080-1086, 1990
50. 50. Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD, Berkelman RL: A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265: 1985-1990, 1991
51. 51. Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH, Speizer FE: Postmenopausal hormone replacement and mortality. New Engl J Med 336: 1769-1775, 1997
52. 52. LaCroix AZ, Burke W: Breast cancer and hormone replacement. Lancet 350: 1042-1043, 1997
53. 53. Sterns EE: Age related breast diagnosis. Can J Surg 35: 41-45, 1992
54. 54. Dupont WD, Page DL: Menopausal estrogen replacement therapy and a breast cancer. Arch Int Med 151: 67-72, 1991
55. 55. Henrich J: The postmenopausal estrogen/breast cancer controversy. JAMA 268: 1900-1902, 1992
56. 56. Helzlsouer KJ, Couzi R: Hormones and breast cancer. Cancer 76: 2059-2063, 1995
57. 57. Newcomb PA, Longnecker MP, Storer BE, Mittendorf R, Baron J, Clapp RW, Bogdan G, Willett WC: Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 142: 788-795, 1995
58. 58. Sellers TA, Mink PJ, Cerhan JR, Zheng W, Anderson KE, Kushi LH, Folsom AR: The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. Annals Internal Med 127: 973-980, 1997
59. 59. Beral V, Banks E, Reeves G, Wallis M: Hormone replacement therapy and high incidence of breast cancer between mammographic screens. Lancet 349: 1103-1104, 1997
60. 60. Kaufman Z, Garstin WIH, Hayes R, Michell MJ, Baum M: The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 43: 389-392, 1991
61. 61. van Gils CH, Otten JDM, Verbeek AL, Hendriks JH, Holland R: Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands. J Epidemiol Communit Health 52: 267-271, 1998
62. 62. Litherland JC, Evans AJ, Wilson AR: The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme. Clin Radio 52: 276-279, 1997
63. 63. Laya MB, Larson EB, Taplin SH, White E: Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 88: 643-649, 1996
64. 64. Thurfjell EL, Holmberg LH, Persson IR: Screening mammography: sensitivity and specificity in relation to hormone replacement therapy. Radiology 203: 339-341, 1997